» Articles » PMID: 38191877

Recombinant Pneumolysin of Pneumococci Induces TLR4 Expression and Maturation of Dendritic Cells In Vitro

Overview
Publisher Springer
Specialty General Medicine
Date 2024 Jan 9
PMID 38191877
Authors
Affiliations
Soon will be listed here.
Abstract

Pneumolysin (Ply) is a target for the development of serotype-independent pneumococcal vaccines, an important condition for the efficacy of which is their ability to activate innate immunity with the subsequent formation of adaptive immunity. In this study, the ability of recombinant full-length Ply (rPly) of pneumococci to induce TLR expression and maturation of dendritic cells generated from mouse bone marrow was evaluated. It was shown that rPly in vitro increased the number of dendritic cells expressing Toll-like receptor 4 (TLR4) on the membrane. rPly caused maturation of dendritic cells generated from mouse bone marrow, which manifested in a decrease in the number of progenitor cells (CD34), an increase in the number of cells expressing the adhesion molecule CD38, costimulatory molecules CD80 and CD86, molecules of terminal differentiation of dendritic cells CD83, as well as molecules of antigenic presentation of the major histocompatibility complex class II.

References
1.
Hu S, Wang P, Dong Y, Li F . Incidence, prevalence and disability of spinal cord injury in China from 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019. Eur Spine J. 2022; 32(2):590-600. DOI: 10.1007/s00586-022-07441-2. View

2.
Geno K, Gilbert G, Song J, Skovsted I, Klugman K, Jones C . Pneumococcal Capsules and Their Types: Past, Present, and Future. Clin Microbiol Rev. 2015; 28(3):871-99. PMC: 4475641. DOI: 10.1128/CMR.00024-15. View

3.
Cima Cabal M, Molina F, Lopez-Sanchez J, Perez-Santin E, Del Mar Garcia-Suarez M . Pneumolysin as a target for new therapies against pneumococcal infections: A systematic review. PLoS One. 2023; 18(3):e0282970. PMC: 10032530. DOI: 10.1371/journal.pone.0282970. View

4.
Chiu F, Leng C, Ding Y, Chang J, Chang L, Lien S . Domain 4 of pneumolysin from Streptococcus pneumoniae is a multifunctional domain contributing TLR4 activating and hemolytic activity. Biochem Biophys Res Commun. 2019; 517(4):596-602. DOI: 10.1016/j.bbrc.2019.07.063. View

5.
Nishimoto A, Rosch J, Tuomanen E . Pneumolysin: Pathogenesis and Therapeutic Target. Front Microbiol. 2020; 11:1543. PMC: 7343714. DOI: 10.3389/fmicb.2020.01543. View